Calendar
August 21, 2026 (7:00am CEST) - Interim Report Q2 2026
September 14-16, 2026 - Morgan Stanley 24th Annual Global Healthcare Conference
November 6, 2026 (7:00am CET) - Interim Report Q3 2026
Investors
Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: [email protected]
